Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 9.56
+0.01 (0.10%)
Sep 4, 2026, 5:07 PM GMT
Scancell Holdings Income Statement
Financials in millions GBP. Fiscal year is May - April.
Millions GBP. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| 4.71 | 4.71 | - | 5.27 | - | - | |
Revenue Growth | - | - | - | - | - | - |
Cost of Revenue | 0.24 | 0.24 | - | 0.53 | - | - |
Gross Profit | 4.47 | 4.47 | - | 4.75 | - | - |
Selling, General & Admin | 5.03 | 4.79 | 5.4 | 5.02 | 4.79 | 3.35 |
Research & Development | 12.79 | 14.69 | 12.87 | 11.65 | 9.48 | 6.41 |
Operating Expenses | 17.82 | 19.47 | 18.27 | 16.67 | 14.26 | 9.75 |
Operating Income | -13.35 | -15 | -18.27 | -11.92 | -14.26 | -9.75 |
Interest Expense | -1.9 | -1.72 | -1.09 | -1.22 | -1.78 | -1.65 |
Interest & Investment Income | 0.38 | 0.34 | 0.36 | 0.28 | 0 | 0 |
Other Non Operating Income (Expenses) | 6.62 | -0.74 | 9.88 | -1.45 | 16.04 | -6.32 |
EBT Excluding Unusual Items | -8.25 | -17.12 | -9.12 | -14.3 | 0.01 | -17.72 |
Other Unusual Items | -0.02 | 1.82 | - | - | -6.28 | 0.92 |
Pretax Income | -8.27 | -15.3 | -9.12 | -14.3 | -6.27 | -16.81 |
Income Tax Expense | -2.76 | -3.03 | -3.26 | -2.37 | -1.7 | -1.33 |
Net Income | -5.51 | -12.27 | -5.86 | -11.94 | -4.57 | -15.48 |
Net Income to Common | -5.51 | -12.27 | -5.86 | -11.94 | -4.57 | -15.48 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,024 | 970 | 862 | 816 | 815 | 679 |
Shares Outstanding (Diluted) | 1,024 | 970 | 1,030 | 816 | 815 | 679 |
Shares Change | 11.62% | -5.78% | 26.19% | 0.10% | 20.13% | 48.75% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
Free Cash Flow | -8.66 | -6.41 | -15.84 | -8.34 | -11.46 | -8.55 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Gross Margin | 94.95% | 94.95% | - | 90.04% | - | - |
Operating Margin | -283.34% | -318.43% | - | -226.14% | - | - |
Profit Margin | -116.98% | -260.50% | - | -226.45% | - | - |
Free Cash Flow Margin | -183.89% | -136.13% | - | -158.28% | - | - |
EBITDA | -12.96 | -14.51 | -17.71 | -11.38 | -13.88 | -9.64 |
EBITDA Margin | -275.16% | - | - | -215.97% | - | - |
D&A For EBITDA | 0.39 | 0.49 | 0.56 | 0.54 | 0.38 | 0.12 |
EBIT | -13.35 | -15 | -18.27 | -11.92 | -14.26 | -9.75 |
EBIT Margin | -283.34% | - | - | -226.14% | - | - |